CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 868
EU - Europa 515
AS - Asia 417
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 1
Totale 1.828
Nazione #
US - Stati Uniti d'America 859
CN - Cina 291
SE - Svezia 197
IE - Irlanda 186
SG - Singapore 63
IT - Italia 62
TR - Turchia 34
CI - Costa d'Avorio 21
DE - Germania 21
FI - Finlandia 17
IN - India 16
IR - Iran 12
CA - Canada 8
BE - Belgio 7
EU - Europa 6
CZ - Repubblica Ceca 4
HU - Ungheria 4
RO - Romania 3
ES - Italia 2
FR - Francia 2
GB - Regno Unito 2
HR - Croazia 2
NL - Olanda 2
BR - Brasile 1
JP - Giappone 1
LT - Lituania 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 1.828
Città #
Chandler 307
Dublin 174
Ashburn 63
Nanjing 59
Dearborn 55
Shanghai 52
Beijing 44
Singapore 40
Boardman 34
Princeton 30
Izmir 28
Ann Arbor 23
New York 22
Abidjan 21
Helsinki 17
Wilmington 17
Los Angeles 14
Parma 14
Pune 14
San Mateo 14
Hefei 13
Nanchang 13
Shenyang 12
Tianjin 12
Changsha 11
Kunming 9
Jiaxing 8
Jinan 8
Brussels 7
Norwalk 7
Bremen 6
Kocaeli 6
Toronto 6
Chengdu 5
Guangzhou 5
Hangzhou 5
Hebei 5
Menlo Park 5
Munich 5
Santa Clara 5
Zanjan 5
Cambridge 4
Ningbo 4
Andover 3
Augusta 3
Brno 3
Frattamaggiore 3
Grafing 3
Houston 3
Milan 3
Rio Saliceto 3
Sacramento 3
Seattle 3
Timisoara 3
Budapest 2
Clifton 2
Cornaredo 2
Dallas 2
Debrecen 2
Falls Church 2
Fremont 2
Leawood 2
Leipzig 2
Padova 2
Port de Sagunt 2
Sezze 2
Taizhou 2
Washington 2
Zagreb 2
Bangalore 1
Baotou 1
Borås 1
Cagliari 1
Changchun 1
Chisinau 1
Des Moines 1
Duncan 1
Florence 1
Fuzhou 1
Glasgow 1
Haikou 1
Harbin 1
London 1
Magdeburg 1
Marseille 1
Mexico City 1
Moscow 1
Mumbai 1
Olomouc 1
Orange 1
Oslo 1
Phoenix 1
Pomigliano d'Arco 1
Portland 1
Quzhou 1
Rockville 1
Shaoxing 1
Stockholm 1
Suzzara 1
São Paulo 1
Totale 1.302
Nome #
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 121
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 77
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 72
Does chronic hypercalcemia influence serum pepsinogens levels? 71
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 69
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 67
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 65
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 64
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 62
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 61
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 61
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 59
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 59
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 58
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 58
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 58
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 57
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 57
Serum pepsinogen II for early assessment of success of H. pylori eradication 57
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 55
Gastro panel® for detection of atrophic gastritis: The “Parma model” 54
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 53
A new curcumin-based one week therapy for eradication of H. pylori infection 53
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 52
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 51
Cancro gastrico e Helicobacter pylori 49
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 46
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 43
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 43
La diagnosi sierologica delle gastriti croniche atrofiche 39
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 39
null 30
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 14
Totale 1.874
Categoria #
all - tutte 7.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 3 1 9 45 30 6 11 14 10 0
2020/202149 1 0 3 0 0 0 0 0 3 30 8 4
2021/2022244 7 11 1 44 29 6 12 11 10 15 32 66
2022/2023808 67 99 71 86 56 100 5 64 223 4 31 2
2023/2024279 11 19 5 6 21 68 23 32 10 17 36 31
2024/2025116 37 39 40 0 0 0 0 0 0 0 0 0
Totale 1.874